From: Lack of shared neoantigens in prevalent mutations in cancer
FRAMESHIFT | TOT FREQ | TOP FREQ | TUMOR | ||
---|---|---|---|---|---|
PROTEIN | PEPTIDE | A*02:01 | |||
RFN43 G659Vfs*41 | TQLARFFPI | 35.39 | 1.23% | N/A | N/A |
SPECC1 N303Tfs*63 | QMLPTLSTL | 69.86 | 0.36% | N/A | N/A |
SPECC1 N303Tfs*63 | LLLGVPQTA | 72.97 | 0.36% | N/A | N/A |
ARID1A D1850Tfs*33 | CLPGLTHPA | 94.71 | 0.34% | N/A | N/A |
CSMD3 F3640Lfs*61 | FLHLYLQDL | 34.80 | 0.28% | N/A | N/A |
CSMD3 F3640Lfs*61 | YLQDLDFIF | 61.21 | 0.28% | N/A | N/A |
ARID1A2 F2141Sfs*59 | WLRGTAWQL | 65.54 | 0.22% | N/A | N/A |
PROTEIN | PEPTIDE | A*03:01 | |||
CSMD3 F3640Lfs*61 | SIQDVQFMK | 89.24 | 0.28% | N/A | N/A |
CSMD3 F3640Lfs*61 | ITMAKQLLK | 9.19 | 0.28% | N/A | N/A |
PROTEIN | PEPTIDE | A*24:02 | |||
N/A | N/A | N/A | N/A | ||
PROTEIN | PEPTIDE | B*07:02 | |||
RFN43 G659Vfs*41 | HPQRKRRGV | 73.06 | 1.23% | N/A | N/A |
RFN43 G659Vfs*41 | VPPSPPLAL | 84.22 | 1.23% | N/A | N/A |
SPECC1 N303Tfs*63 | TPLRVQSVL | 26.51 | 0.36% | N/A | N/A |
BRD3 P24Rfs*24 | SPTPASPAA | 82.17 | 0.24% | N/A | N/A |
BRD3 P24Rfs*24 | SPAARPTSC | 58.76 | 0.24% | N/A | N/A |
ARID1A2 F2141Sfs*59 | WPTWLRGTA | 40.77 | 0.22% | N/A | N/A |
ARID1A2 F2141Sfs*59 | VPLQCRRAV | 9.78 | 0.22% | N/A | N/A |
PROTEIN | PEPTIDE | B*08:02 | |||
RFN43 G659Vfs*41 | TQLARFFPI | 48.47 | 1.23% | N/A | N/A |
LARP4B T163Hfs*47 | VLKKHWNSA | 59.58 | 0.43% | N/A | N/A |
PROTEIN | PEPTIDE | B*27:05 | |||
SPECC1 N303Tfs*63 | LRVQSVLLL | 46.92 | 0.36% | N/A | N/A |
ARID1A D1850Tfs*33 | WRIGGGTPL | 51.15 | 0.34% | N/A | N/A |
CTCF T204Nfs*26 | QRCRCVCLR | 94.17 | 0.32% | N/A | N/A |
PROTEIN | PEPTIDE | B*39:01 | |||
RFN43 G659Vfs*41 | TQLARFFPI | 87.73 | 1.23% | N/A | N/A |
LARP4B T163Hfs*47 | YHRWIVTSM | 71.78 | 0.43% | N/A | N/A |
SPECC1 N303Tfs*63 | HQAPQVAML | 80.74 | 0.36% | N/A | N/A |
ARID1A D1850Tfs*33 | WRIGGGTPL | 6.08 | 0.34% | N/A | N/A |
BLM N515Mfs*16 | MKALISQEM | 85.03 | 0.22% | N/A | N/A |
BLM N515Mfs*16 | SQEMFSQAL | 35.43 | 0.22% | N/A | N/A |
PROTEIN | PEPTIDE | B*40:01 | |||
BLM N515Mfs*16 | QEMFSQALL | 8.02 | 0.22% | N/A | N/A |
PROTEIN | PEPTIDE | B*58:01 | |||
LARP4B T163Hfs*47 | VTCILYHRW | 12.22 | 0.43% | N/A | N/A |
LARP4B T163Hfs*47 | TSMCQSQRW | 10.43 | 0.43% | N/A | N/A |
B2M L15Ffs*41 | AVLALLSFW | 32.16 | 0.25% | N/A | N/A |
BRD3 P24Rfs*24 | TSCSTCRMW | 30.06 | 0.24% | N/A | N/A |
ARID1A2 F2141Sfs*59 | LATPPSAAW | 7.45 | 0.22% | N/A | N/A |
BLM N515Mfs*16 | KALISQEMF | 23.69 | 0.22% | N/A | N/A |
PROTEIN | PEPTIDE | B*15:01 | |||
UBR5 E2121Kfs*28 | VQNQGHLLM | 37.86 | 0.49% | N/A | N/A |
CTCF T204Nfs*26 | NQKEQTALY | 58.38 | 0.32% | N/A | N/A |
CSMD3 F3640Lfs*61 | CMTPTQSQW | 31.13 | 0.28% | N/A | N/A |